← GSK plc
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $27.9b |
$30.2b
+8.24%
|
$30.8b
+2.10%
|
$33.8b
+9.52%
|
$34.1b
+1.02%
|
$34.1b
+0.04%
|
$29.3b
-14.04%
|
$30.3b
+3.42%
|
$31.4b
+3.46%
|
$32.7b
+4.11%
|
$33.2b
+1.64%
|
|
| Cost of Goods and Services Sold | $9.3b |
$10.3b
+11.32%
|
$10.2b
-0.98%
|
$11.9b
+15.84%
|
$11.7b
-1.34%
|
$11.6b
-0.86%
|
$9.6b
-17.66%
|
$8.6b
-10.35%
|
$9.0b
+5.64%
|
$9.0b
-0.34%
|
$9.1b
+0.43%
|
|
| Gross Profit | $18.6b |
$19.8b
+6.69%
|
$20.6b
+3.71%
|
$21.9b
+6.37%
|
$22.4b
+2.30%
|
$22.5b
+0.52%
|
$19.8b
-12.18%
|
$21.8b
+10.08%
|
$22.3b
+2.60%
|
$23.6b
+5.92%
|
$24.1b
+2.10%
|
|
| Research and development | $3.6b | $4.5b | $3.9b | $4.6b | $5.1b | $5.3b | $5.5b | $6.2b | $6.4b | $7.5b | $9.2b | |
| Selling, General and Administrative Expense | $9.4b | $9.7b | $9.9b | $11.4b | $11.5b | $11.0b | $8.4b | $9.4b | $11.0b | $9.1b | $9.2b | |
| Operating expenses: | ||||||||||||
| Other Operating Income Expense | ($3.4b) | ($2.0b) | ($1.6b) | $689.0m | $1.6b | ($476.0m) | ($235.0m) | ($363.0m) | ($1.5b) | $16.0m | — | |
| Interest Expense | — | — | — | — | — | $775.0m | $912.0m | — | — | — | $690.0m | |
| Interest Expense On Lease Liabilities | — | — | — | $39.0m | $40.0m | $31.0m | $30.0m | $38.0m | $46.0m | $46.0m | $690.0m | |
| Other Income | $23.0m | $9.0m | ($7.0m) | — | — | — | — | — | — | — | — | |
| Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method | $5.0m | $13.0m | $31.0m | $74.0m | $33.0m | $33.0m | ($2.0m) | ($5.0m) | ($3.0m) | $1.0m | — | |
| Deferred Tax Expense (Income) | ($541.0m) | ($263.0m) | ($414.0m) | ($183.0m) | ($693.0m) | ($1.0b) | ($784.0m) | ($865.0m) | ($1.0b) | ($283.0m) | — | |
| Deferred Tax Expense (Income) Recognised In Profit Or Loss | — | $247.0m | $396.0m | — | — | — | — | — | — | — | — | |
| Income Tax Expense Continuing Operations | $877.0m | $1.4b | $754.0m | $953.0m | $580.0m | $346.0m | $707.0m | $756.0m | $526.0m | $1.1b | $641.0m | |
| Basic Earnings (Loss) Per Share | $0.19 | $0.31 | $0.74 | $0.94 | $1.16 | $0.88 | $3.71 | $1.22 | $0.63 | $1.41 | $2.40 | |
| Diluted Earnings (Loss) Per Share | $0.19 | $0.31 | $0.73 | $0.93 | $1.14 | $0.87 | $3.66 | $1.20 | $0.62 | $1.39 | $2.36 | |
| Additional Financial Items | ||||||||||||
| Applicable Tax Rate | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | — | — | — | |
| Auditors Remuneration For Tax Services | $200k | $200k | $100k | — | — | — | — | — | — | — | — | |
| Average Effective Tax Rate | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | |
| Depreciation And Amortisation Expense | $1.8b | $1.9b | $1.9b | $2.3b | $2.4b | $2.4b | $2.1b | $2.3b | $2.6b | $2.3b | — | |
| Depreciation Right of Use Assets | — | — | — | $214.0m | $225.0m | $213.0m | $176.0m | $190.0m | $211.0m | $206.0m | — | |
| Employee Benefits Expense | $8.2b | $9.1b | $9.4b | $9.9b | $10.2b | $9.0b | $7.7b | $8.5b | $8.8b | $8.8b | — | |
| Expense From Share-Based Payment Transactions With Employees | $338.0m | $347.0m | $393.0m | $432.0m | $393.0m | $404.0m | $314.0m | $321.0m | $347.0m | $390.0m | — | |
| Expense Relating To Leases Of Low-Value Assets For Which Recognition Exemption Has Been Used | — | — | — | $4.0m | $5.0m | $3.0m | $2.0m | $2.0m | $2.0m | — | — | |
| Expense Relating To Short-Term Leases For Which Recognition Exemption Has Been Used | — | — | — | $12.0m | $11.0m | $7.0m | $6.0m | $8.0m | $13.0m | — | — | |
| Expense Relating To Variable Lease Payments Not Included In Measurement Of Lease Liabilities | — | — | — | $13.0m | $11.0m | $10.0m | $9.0m | $17.0m | $15.0m | — | — | |
| Finance Costs | $736.0m | $734.0m | $798.0m | $912.0m | $892.0m | $784.0m | $879.0m | $792.0m | $669.0m | $701.0m | — | |
| Finance Income | $72.0m | $65.0m | $81.0m | $98.0m | $44.0m | $28.0m | $76.0m | $115.0m | $122.0m | $169.0m | — | |
| Impairment Loss Recognised In Profit Or Loss Goodwill | — | — | — | $4.0m | — | — | — | — | — | — | — | |
| Impairment Loss Recognised In Profit Or Loss Intangible Assets Other Than Goodwill | $22.0m | $690.0m | $134.0m | $126.0m | $257.0m | — | — | — | $317.0m | $888.0m | — | |
| Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | — | — | — | — | — | — | — | — | ($12.0m) | $4.0m | — | |
| Postemployment Benefit Expense Defined Benefit Plans | — | — | — | — | — | — | — | — | $218.0m | $170.0m | — | |
| Postemployment Benefit Expense Defined Contribution Plans | — | — | — | — | — | — | — | — | $150.0m | $130.0m | — | |
| Profit Loss Attributable To Noncontrolling Interests | $150.0m | $637.0m | $423.0m | $623.0m | $639.0m | $711.0m | $665.0m | $380.0m | $376.0m | $573.0m | — | |
| Profit Loss Attributable To Owners Of Parent | $912.0m | $1.5b | $3.6b | $4.6b | $5.7b | $4.4b | $15.0b | $4.9b | $2.6b | $5.7b | — | |
| Profit Loss Before Tax | $1.9b | $3.5b | $4.8b | $6.2b | $7.0b | $5.4b | $5.6b | $6.1b | $3.5b | $7.4b | — | |
| Profit Loss From Operating Activities | $2.6b | $4.1b | $5.5b | $7.0b | $7.8b | $6.2b | $6.4b | $6.7b | $4.0b | $7.9b | — | |
| Tax Rate Effect Of Foreign Tax Rates | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | ($0) | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.